A novel NKX2-5 mutation in familial ventricular septal defect

International Journal of Molecular Medicine

Volumn 27, Issue 3, 2011, Pages 369-375

  Wang, Juan ^a   Xin, Yuan Feng ^a   Liu, Xing Yuan ^a   Liu, Zhong Min ^a   Wang, Xiao Zhong ^b   Yang, Yi Qing ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Genetics; Transcription factor; Ventricular septal defect

Indexed keywords

GENOMIC DNA; HOMEODOMAIN PROTEIN; RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NKX2 5 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC DISEASES, INBORN; HEART SEPTAL DEFECTS, VENTRICULAR; HOMEODOMAIN PROTEINS; HUMANS; MALE; MUTATION, MISSENSE; TRANSCRIPTION FACTORS;

EID: 79551609535     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.585     Document Type: Article

References (51)

1. Lloyd-Jones D, Adams R, Carnethon M, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-e181, 2009.
2. Minette MS and Sahn DJ: Ventricular septal defects. Circulation 114: 2190-2197, 2006.
3. Sommer RJ, Hijazi ZM and Rhodes JF Jr: Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions. Circulation 117: 1090-1099, 2008.
4. McQuillen PS and Miller SP: Congenital heart disease and brain development. Ann NY Acad Sci 1184: 68-86, 2010.
5. Walsh EP: Interventional electrophysiology in patients with congenital heart disease. Circulation 115: 3224-3234, 2007
6. Walsh EP and Cecchin F: Arrhythmias in adult patients with congenital heart disease. Circulation 115: 534-545, 2007
7. Yap SC and Harris L: Sudden cardiac death in adults with congenital heart disease. Expert Rev Cardiovasc Ther 7: 1605-1620, 2009.
8. Jenkins KJ, Correa A, Feinstein JA, et al: American Heart Association Council on Cardiovascular Disease in the Young: Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014, 2007
9. Pierpont ME, Basson CT, Benson DW Jr, et al: American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038, 2007
10. Pemberton VL, McCrindle BW, Barkin S, et al: Report of the National Heart, Lung, and Blood Institute's Working Group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation 121: 1153-1159, 2010.
11. Schott JJ, Benson DW, Basson CT, et al: Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111, 1998.
12. Biben C, Weber R, Kesteven S, et al: Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87: 888-895, 2000.
13. Hiroi Y, Kudoh S, Monzen K, et al: Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 28: 276-280, 2001.
14. Pashmforoush M, Lu JT, Chen H, et al: Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386, 2004.
15. Prall OW, Menon MK, Solloway MJ, et al: An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947-959, 2007
16. Moskowitz IP, Kim JB, Moore ML, et al: A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129: 1365-1376, 2007
17. Akazawa H and Komuro I: Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases. Pharmacol Ther 107: 252-268, 2005.
18. Stallmeyer B, Fenge H, Nowak-Göttl U and Schulze-Bahr E: Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet 78: 533-540, 2010.
19. Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al: Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104: 1567-1573, 1999.
20. Gutierrez-Roelens I, Sluysmans T, Gewillig M, Devriendt K and Vikkula M: Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum Mutat 20: 75-76, 2002.
21. McElhinney DB, Geiger E, Blinder J, Benson DW and Goldmuntz E: NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42: 1650-1655, 2003.
22. Kasahara H and Benson DW: Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res 64: 40-51, 2004.
23. Sarkozy A, Conti E, Neri C, et al: Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42: e16, 2005.
24. Pabst S, Wollnik B, Rohmann E, et al: A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin Res Cardiol 97: 39-42, 2008.
25. Reamon-Buettner SM, Hecker H, Spanel-Borowski K, Craatz S, Kuenzel E and Borlak J: Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations. Am J Pathol 164: 2117-2125, 2004.
26. Reamon-Buettner SM and Borlak J: Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J Med Genet 41: 684-690, 2004.
27. Draus JM Jr, Hauck MA, Goetsch M, Austin EH III, Tomita-Mitchell A and Mitchell ME: Investigation of somatic NKX2-5 mutations in congenital heart disease. J Med Genet 46: 115-122, 2009.
28. Garg V, Kathiriya IS, Barnes R, et al: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447, 2003.
29. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V and Goldmuntz E: GATA4 sequence variants in patients with congenital heart disease. J Med Genet 44: 779-783, 2007
30. Basson CT, Bachinsky DR, Lin RC, et al: Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15: 30-35, 1997
31. Li QY, Newbury-Ecob RA, Terrett JA, et al: Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15: 21-29, 1997
32. Maitra M, Koenig SN, Srivastava D and Garg V: Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res 68: 281-285, 2010.
33. Lin X, Huo Z, Liu X, et al: A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. J Hum Genet 55: 662-667, 2010.
34. Yang SW, Hitz MP and Andelfinger G: Ventricular septal defect and restrictive cardiomyopathy in a paediatric TNNI3 mutation carrier. Cardiol Young 20: 574-576, 2010.
35. Granados-Riveron JT, Ghosh TK, Pope M, et al: Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet 19: 4007-4016, 2010.
36. Hirayama-Yamada K, Kamisago M, Akimoto K, et al: Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 135: 47-52, 2005.
37. Hosoda T, Komuro I, Shiojima I, et al: Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/KX2-5 in a Japanese patient. Jpn Circ J 63: 425-426, 1999.
38. Bodmer R: The gene, tinman, is required for specification of the heart and visceral muscles in Drosophilia. Development 118: 719-729, 1993.
39. Grow MW and Krieg PA: Tinman function is essential for vertebrate heart development: elimination of cardiac differentiation by dominant inhibitory mutants of the tinman-related genes, XNkx2-3 and XNkx2-5. Dev Biol 204: 187-196, 1998.
40. Kasahara H, Wakimoto H, Liu M, et al: Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J Clin Invest 108: 189-201, 2001.
41. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L and Harvey RP: Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9: 1654-1666, 1995.
42. Tanaka M, Chen Z, Bartunkova S, Yamasaki N and Izumo S: The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126: 1269-1280, 1999.
43. Briggs LE, Takeda M, Cuadra AE, et al: Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ Res 103: 580-590, 2008.
44. Durocher D, Chen CY, Ardati A, Schwartz RJ and Nemer M: The atrial natriuretic factor promoter is a downstream target for Nkx2-5 in the myocardium. Mol Cell Biol 16: 4648-4655, 1996.
45. Chen CY, Croissant J, Majesky M, Topouzis S, McQuinn T, Frankovsky MJ and Schwartz RJ: Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx2-5, and intact serum response elements. Dev Genet 19: 119-130, 1996.
46. Durocher D, Charron F, Warren R, Schwartz RJ and Nemer M: The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 16: 5687-5696, 1997
47. Lee Y, Shioi T, Kasahara H, Jobe SM, Wiese RJ, Markham BE and Izumo S: The cardiac tissue-restricted homeobox protein Csx/Nkx2-5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol 18: 3120-3129, 1998.
48. Shiojima I, Komuro I, Oka T, et al: Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx2.5 and GATA-4. J Biol Chem 274: 8231-8239, 1999.
49. Zhu W, Shiojima I, Hiroi Y, et al: Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J Biol Chem 275: 35291-35296, 2000.
50. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, Seidman CE and Izumo S: Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 106: 299-308, 2000.
51. Inga A, Reamon-Buettner SM, Borlak J and Resnick MA: Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum Mol Genet 14: 1965-1975, 2005.